Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension?

This study has been completed.
Sponsor:
Collaborators:
Chief Scientist Office of the Scottish Government
NHS Tayside
NHS Fife
Information provided by (Responsible Party):
A. D. Struthers, University of Dundee
ClinicalTrials.gov Identifier:
NCT01197469
First received: September 1, 2010
Last updated: November 5, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
No publications provided by University of Dundee

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):